Previously Known As : Sbi Pharma Fund
Sbi Healthcare Opportunities Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 29-07-2026
NAV ₹512.59(R) +1.29% ₹593.08(D) +1.29%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 15.2% 23.07% 17.42% 24.86% 13.41%
Direct 16.36% 24.35% 18.66% 26.2% 14.66%
Nifty Pharma TRI 15.01% 21.55% 14.5% 19.4% 9.23%
SIP (XIRR) Regular 35.38% 21.08% 22.33% 22.58% 19.31%
Direct 36.69% 22.32% 23.6% 23.89% 20.52%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.2 0.63 1.09 2.39% 0.23
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.65% -15.67% -12.33% 0.82 10.68%
Fund AUM As on: 30/12/2025 4058 Cr

NAV Date: 29-07-2026

Scheme Name NAV Rupee Change Percent Change
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 322.9
4.1000
1.2900%
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 412.06
5.2400
1.2900%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 512.59
6.5100
1.2900%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 593.08
7.5500
1.2900%

Review Date: 29-07-2026

Beginning of Analysis

The SBI Healthcare Opportunities Fund has shown an excellent past performence in Pharma Fund. The SBI Healthcare Opportunities Fund has a Jensen Alpha of 2.39% which is higher than the category average of 1.66%. Here the SBI Healthcare Opportunities Fund has shown good performance in terms of risk adjusted returns. The SBI Healthcare Opportunities Fund has a Sharpe Ratio of 1.2 which is higher than the category average of 1.04. Here the SBI Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

SBI Healthcare Opportunities Fund Return Analysis

The SBI Healthcare Opportunities Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of 4.75%, 17.24 and 27.98 in last one, three and six months respectively. In the same period the category average return was 4.48%, 14.6% and 24.83% respectively.
  • SBI Healthcare Opportunities Fund has given a return of 16.36% in last one year. In the same period the Nifty Pharma TRI return was 15.01%. The fund has given 1.35% more return than the benchmark return.
  • The fund has given a return of 24.35% in last three years and rank 2nd out of ten funds in the category. In the same period the Nifty Pharma TRI return was 21.55%. The fund has given 2.8% more return than the benchmark return.
  • SBI Healthcare Opportunities Fund has given a return of 18.66% in last five years and category average returns is 16.38% in same period. The fund ranked 1.0st out of eight funds in the category. In the same period the Nifty Pharma TRI return was 14.5%. The fund has given 4.16% more return than the benchmark return.
  • The fund has given a return of 14.66% in last ten years and ranked 4.0th out of four funds in the category. In the same period the Nifty Pharma TRI return was 9.23%. The fund has given 5.43% more return than the benchmark return.
  • The fund has given a SIP return of 36.69% in last one year whereas category average SIP return is 31.69%. The fund one year return rank in the category is 5th in 16 funds
  • The fund has SIP return of 22.32% in last three years and ranks 1st in 9 funds. The fund has given the highest SIP return in the category in last three years.
  • The fund has SIP return of 23.6% in last five years whereas category average SIP return is 20.84%.

SBI Healthcare Opportunities Fund Risk Analysis

  • The fund has a standard deviation of 14.65 and semi deviation of 10.68. The category average standard deviation is 15.94 and semi deviation is 11.38.
  • The fund has a Value at Risk (VaR) of -15.67 and a maximum drawdown of -12.33. The category average VaR is -18.94 and the maximum drawdown is -14.76. The fund has a beta of 0.77 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

  • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 4.67 4.75
    4.36
    2.43 | 5.59 8 | 17 Good
    3M Return % 16.96 13.73
    14.21
    9.92 | 17.02 2 | 17 Very Good
    6M Return % 27.36 22.96
    23.99
    17.92 | 30.88 5 | 17 Very Good
    1Y Return % 15.20 15.01
    12.09
    5.47 | 18.40 5 | 16 Good
    3Y Return % 23.07 21.55
    20.95
    18.63 | 23.30 3 | 10 Very Good
    5Y Return % 17.42 14.50
    15.00
    13.35 | 17.42 1 | 8 Very Good
    7Y Return % 24.86 19.40
    22.87
    19.95 | 24.86 1 | 8 Very Good
    10Y Return % 13.41 9.23
    13.72
    12.92 | 14.96 3 | 4 Average
    15Y Return % 17.21 12.71
    16.14
    14.88 | 17.21 1 | 3 Very Good
    1Y SIP Return % 35.38
    30.22
    19.95 | 39.32 4 | 15 Very Good
    3Y SIP Return % 21.08
    17.39
    13.96 | 21.08 1 | 8 Very Good
    5Y SIP Return % 22.33
    19.61
    17.34 | 22.33 1 | 7 Very Good
    7Y SIP Return % 22.58
    20.33
    18.66 | 22.58 1 | 7 Very Good
    10Y SIP Return % 19.31
    18.19
    17.31 | 19.31 1 | 4 Very Good
    15Y SIP Return % 17.12
    16.54
    15.73 | 17.12 1 | 3 Very Good
    Standard Deviation 14.65
    15.95
    14.65 | 16.87 1 | 8 Very Good
    Semi Deviation 10.68
    11.39
    10.68 | 12.13 1 | 8 Very Good
    Max Drawdown % -12.33
    -14.76
    -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67
    -18.95
    -23.32 | -15.67 1 | 8 Very Good
    Average Drawdown % 5.39
    5.47
    3.66 | 6.79 5 | 8 Average
    Sharpe Ratio 1.20
    1.04
    0.87 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09
    0.94
    0.81 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63
    0.54
    0.44 | 0.63 1 | 8 Very Good
    Jensen Alpha % 2.39
    1.66
    -0.46 | 3.84 4 | 8 Good
    Treynor Ratio 0.23
    0.20
    0.16 | 0.23 1 | 8 Very Good
    Modigliani Square Measure % 19.86
    17.20
    14.35 | 19.86 1 | 8 Very Good
    Alpha % -0.61
    0.06
    -1.73 | 3.02 4 | 8 Good
    Return data last Updated On : July 29, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 4.75 4.75 4.48 2.50 | 5.79 8 | 17 Good
    3M Return % 17.24 13.73 14.60 10.15 | 17.47 2 | 17 Very Good
    6M Return % 27.98 22.96 24.83 18.41 | 31.91 5 | 17 Very Good
    1Y Return % 16.36 15.01 13.62 6.54 | 20.06 5 | 16 Good
    3Y Return % 24.35 21.55 22.43 19.69 | 24.51 2 | 10 Very Good
    5Y Return % 18.66 14.50 16.38 14.37 | 18.66 1 | 8 Very Good
    7Y Return % 26.20 19.40 24.39 21.79 | 26.20 1 | 8 Very Good
    10Y Return % 14.66 9.23 15.01 14.66 | 15.98 4 | 4 Poor
    1Y SIP Return % 36.69 31.69 20.89 | 41.47 5 | 16 Good
    3Y SIP Return % 22.32 18.64 15.56 | 22.32 1 | 9 Very Good
    5Y SIP Return % 23.60 20.84 18.39 | 23.60 1 | 8 Very Good
    7Y SIP Return % 23.89 21.75 20.04 | 23.89 1 | 8 Very Good
    10Y SIP Return % 20.52 19.49 18.95 | 20.52 1 | 4 Very Good
    Standard Deviation 14.65 15.95 14.65 | 16.87 1 | 8 Very Good
    Semi Deviation 10.68 11.39 10.68 | 12.13 1 | 8 Very Good
    Max Drawdown % -12.33 -14.76 -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67 -18.95 -23.32 | -15.67 1 | 8 Very Good
    Average Drawdown % 5.39 5.47 3.66 | 6.79 5 | 8 Average
    Sharpe Ratio 1.20 1.04 0.87 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09 0.94 0.81 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63 0.54 0.44 | 0.63 1 | 8 Very Good
    Jensen Alpha % 2.39 1.66 -0.46 | 3.84 4 | 8 Good
    Treynor Ratio 0.23 0.20 0.16 | 0.23 1 | 8 Very Good
    Modigliani Square Measure % 19.86 17.20 14.35 | 19.86 1 | 8 Very Good
    Alpha % -0.61 0.06 -1.73 | 3.02 4 | 8 Good
    Return data last Updated On : July 29, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Sbi Healthcare Opportunities Fund NAV Regular Growth Sbi Healthcare Opportunities Fund NAV Direct Growth
    29-07-2026 512.5903 593.0834
    28-07-2026 506.081 585.5363
    27-07-2026 506.0488 585.4834
    24-07-2026 496.925 574.8814
    23-07-2026 498.9239 577.1783
    22-07-2026 503.5143 582.4732
    21-07-2026 508.8453 588.6244
    20-07-2026 506.9451 586.4105
    17-07-2026 502.0518 580.7036
    16-07-2026 506.4945 585.8266
    15-07-2026 504.8953 583.9614
    14-07-2026 501.733 580.2884
    13-07-2026 499.1095 577.2386
    10-07-2026 498.6905 576.7078
    09-07-2026 496.7541 574.453
    08-07-2026 489.1688 565.6662
    07-07-2026 493.5933 570.7674
    06-07-2026 499.2669 577.3126
    03-07-2026 501.1098 579.3971
    02-07-2026 496.2487 573.7611
    01-07-2026 491.5942 568.3644
    30-06-2026 492.8655 569.819
    29-06-2026 489.7304 566.1793

    Fund Launch Date: 01/Jan/1993
    Fund Category: Pharma Fund
    Investment Objective: To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
    Fund Description: An open-ended Equity Scheme investing in healthcare sector
    Fund Benchmark: S&P BSE HEALTHCARE Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.